Fidelity Healthy Future Fund (FAPHX)
14.39
+0.10
(+0.70%)
USD |
May 08 2026
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.05% | 14.88M | 1.51% | 48.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -15069.00 | 16.45% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital. It invests in equity securities of companies that FMR believes are working to extend and/or improve life expectancy, enhance health and wellness in people's lives, and/or mitigate environmental impacts affecting health and wellness through products, services or technology. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Fidelity Investments |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
38
-376.88M
Peer Group Low
38.58M
Peer Group High
1 Year
% Rank:
28
-15069.00
-5.978B
Peer Group Low
810.44M
Peer Group High
3 Months
% Rank:
42
-1.028B
Peer Group Low
769.92M
Peer Group High
3 Years
% Rank:
22
-15.49B
Peer Group Low
810.44M
Peer Group High
6 Months
% Rank:
42
-2.384B
Peer Group Low
810.44M
Peer Group High
5 Years
% Rank:
28
-21.48B
Peer Group Low
810.44M
Peer Group High
YTD
% Rank:
46
-1.028B
Peer Group Low
804.51M
Peer Group High
10 Years
% Rank:
38
-43.03B
Peer Group Low
810.44M
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 09, 2026.
Asset Allocation
As of March 31, 2026.
| Type | % Net |
|---|---|
| Cash | 0.38% |
| Stock | 98.49% |
| Bond | 0.57% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.56% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| NVIDIA Corp. | 6.03% | 215.20 | 1.75% |
| Procter & Gamble Co. | 4.70% | 146.42 | 0.25% |
| AIA Group Ltd. | 4.57% | 11.23 | -0.14% |
| Johnson & Johnson | 4.26% | 221.32 | -0.53% |
| Tesla, Inc. | 3.86% | 428.35 | 4.02% |
| Welltower, Inc. | 3.06% | 214.63 | 0.79% |
| Chubb Ltd. | 2.77% | 319.64 | -0.51% |
| Gilead Sciences, Inc. | 2.66% | 131.33 | -2.04% |
| CVS Health Corp. | 2.66% | 90.55 | 3.65% |
| UCB SA | 2.51% | 280.85 | 0.00% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.05% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 0.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital. It invests in equity securities of companies that FMR believes are working to extend and/or improve life expectancy, enhance health and wellness in people's lives, and/or mitigate environmental impacts affecting health and wellness through products, services or technology. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Fidelity Investments |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-7-26) | 0.76% |
| 30-Day SEC Yield (10-3-23) | 0.00% |
| 7-Day SEC Yield (10-3-23) | 0.00% |
| Number of Holdings | 81 |
| Stock | |
| Weighted Average PE Ratio | 30.80 |
| Weighted Average Price to Sales Ratio | 6.498 |
| Weighted Average Price to Book Ratio | 7.005 |
| Weighted Median ROE | 22.97% |
| Weighted Median ROA | 11.08% |
| ROI (TTM) | 15.75% |
| Return on Investment (TTM) | 15.75% |
| Earning Yield | 0.0410 |
| LT Debt / Shareholders Equity | 0.5443 |
| Number of Equity Holdings | 79 |
As of March 31, 2026
Growth Metrics
| EPS Growth (1Y) | 17.35% |
| EPS Growth (3Y) | 18.07% |
| EPS Growth (5Y) | 22.40% |
| Sales Growth (1Y) | 14.08% |
| Sales Growth (3Y) | 15.69% |
| Sales Growth (5Y) | 14.60% |
| Sales per Share Growth (1Y) | 55.29% |
| Sales per Share Growth (3Y) | 15.73% |
| Operating Cash Flow - Growth Rate (3Y) | 22.24% |
As of March 31, 2026
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:FAPHX", "name") |
| Broad Asset Class: =YCI("M:FAPHX", "broad_asset_class") |
| Broad Category: =YCI("M:FAPHX", "broad_category_group") |
| Prospectus Objective: =YCI("M:FAPHX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |